Pancreatic Cancer Research

ResearcherDartmouth CollegeActive in the last 2 years

Kerrington D. Smith

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-7225-2029; OpenAlex author ID A5087377374. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 7

  1. Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer: A Single-Center Retrospective Study. Co-author DOI 10.1097/coc.0000000000001052↗
  2. Tumor microtubes connect pancreatic cancer cells in an Arp2/3 complex-dependent manner. Co-author DOI 10.1091/mbc.e19-11-0605↗
  3. Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma. Last author DOI 10.3389/fonc.2020.01461↗
  4. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled … Co-author DOI 10.1016/j.gie.2016.02.047↗
  5. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and f… Last author DOI 10.18632/oncotarget.7718↗
  6. The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. Co-author DOI 10.1097/mpa.0000000000000162↗
  7. Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Co-author DOI 10.1093/annonc/mds109↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bassem I. Zaki · 4 shared papers, 2012–2024 · strength 0.32
  2. Timothy B. Gardner · 5 shared papers, 2012–2020 · strength 0.32
  3. Gabriel A. Brooks · 1 shared paper, 2024 · strength 0.21
  4. Minerva Nong · 1 shared paper, 2024 · strength 0.21
  5. Katherine V. Trinh · 1 shared paper, 2020 · strength 0.16
  6. Richard J. Barth · 4 shared papers, 2012–2016 · strength 0.16
  7. Stuart R. Gordon · 4 shared papers, 2012–2016 · strength 0.16
  8. Henry N. Higgs · 1 shared paper, 2020 · strength 0.11
  9. Olivera Grbovic-Huezo · 1 shared paper, 2020 · strength 0.11
  10. Casey J. Latario · 1 shared paper, 2020 · strength 0.11
  11. Steven D Leach · 1 shared paper, 2020 · strength 0.11
  12. Gregory J. Tsongalis · 3 shared papers, 2012–2016 · strength 0.10
  13. Arief Antonius Suriawinata · 3 shared papers, 2012–2016 · strength 0.10
  14. J. Marc Pipas · 2 shared papers, 2012–2014 · strength 0.06
  15. Francine Blumental De Abreu · 1 shared paper, 2016 · strength 0.04
  16. Craig R. Tomlinson · 1 shared paper, 2016 · strength 0.04
  17. Robert J. Allaway · 1 shared paper, 2016 · strength 0.04
  18. Kabir Mody · 1 shared paper, 2014 · strength 0.04
  19. Meir Preis · 1 shared paper, 2012 · strength 0.02
  20. Murray Korc · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.